𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase I study of AG 331, a novel thymidylate synthase inhibitor, in patients with refractory solid tumors

✍ Scribed by Robert T. Koda; Agustin A. Garcia; Dhruba J. Chatterjee; Wen Yen Li; Deepika Parimoo; Susan Jeffers; Marion Rogers; C. Gail Leichman; Lawrence Leichman; Ellen Y. Wu; Bhasker V. Shetty; Stephanie Webber; Neil Clendinnin; Franco M. Muggia

Publisher
Springer
Year
1999
Tongue
English
Weight
153 KB
Volume
43
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A Phase I study of 9-nitrocamptothecin g
A Phase I study of 9-nitrocamptothecin given concurrently with capecitabine in patients with refractory, metastatic solid tumors
✍ M. Dror Michaelson; David P. Ryan; Charles S. Fuchs; Jeffrey G. Supko; Rocio Gar πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 83 KB πŸ‘ 1 views

## Abstract ## BACKGROUND 9‐Nitrocamptothecin (9‐NC) is an orally available camptothecin analog with antineoplastic activity that results from the inhibition of DNA topoisomerase I. Previous studies have suggested that it has significant clinical efficacy. The primary toxicities of 9‐NC include ga

A multicenter Phase I safety study of in
A multicenter Phase I safety study of intratumoral photoactivation of talaporfin sodium in patients with refractory solid tumors
✍ Robert A. Lustig; Thomas J. Vogl; David Fromm; Rosa Cuenca; R. Alex Hsi; Anil K. πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 87 KB πŸ‘ 1 views

## Abstract ## BACKGROUND Photodynamic therapy (PDT) currently is approved for the palliative treatment of malignancies of the aerodigestive tract using laser‐activated porfimer sodium. A new approach has been developed, based on intratumoral placement of a nonlaser light device that activates tal